Özet:

Aim: This study aims to determine the malignancy rates of nonpalpable BIRADS 4 breast lesions excised by stereotactic biopsy, the re-excision rates of malignant lesions detected by stereotactic biopsy and to evaluate the factors affecting malignancy rates in these lesions. Materials and Methods: Medical records of female patients admitted to the surgical oncology outpatient clinic between 2012 and 2017 with nonpalpable (<1 cm) BIRADS 4 breast lesions (either detected by USG or mammography) and underwent stereotactic breast biopsy were assessed. Results: The mean age of a total of 208 patients with 235 lesions underwent image-guided breast biopsy was 49.0± 0.6. In 54% of lesions, localization was superior outer quadrant and 51.1% of lesions were at left breast. In 46% of cases, radiological abnormality causing suspicion of malignancy was nodular lesion and the most encountered pathological result was proliferative breast lesion without atypia (62.1%). The mean age of the malignancy detected group after stereotactic biopsy was higher than benign group (p=0.048). In 16.2% (38/235) of the lesions, malignancy was detected and none of malignant lesions had lymph node metastasis. ER, PR and HER-2 positivity were 88.2% (30/34), 86.7% (26/30), and 30% (6/20), respectively. The re-excision rates of the malignant lesions to ensure oncologically acceptable surgical margins were 23.7% (9/38). Conclusion: Although malignancy, re-excision, and lymph node metastasis rates of non-palpable breast lesions underwent stereotactic biopsy with malignancy suspicion are not too high, careful evaluation of these lesions with malignancy suspicion is suggested in order not to miss malignant cases.

Anahtar Kelimeler: